Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...

The patch-delivered vaccine trial received $28.5m in funding from US authorities as a potential pandemic preparation.

The Company is conducting two investigator-initiated clinical trials for its unmodified gamma-delta T cell product line - Phase 2b/3 pivotal trial in the treatment of acute myeloid leukemia using ...

The conundrum of missing data vs. inter-rater variability.

The pivotal clinical phase 3 trial for the olanzapine Long-Acting Injectable (LAI) in schizophrenia (SOLARIS) has been completed, following the final visit of the last patient in the 48 weeks open ...

Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

today announced it has completed enrollment of all four multiple-ascending dose (MAD) cohorts for the Phase 1 clinical trial of SAT-3247 in healthy volunteers. “The completion of healthy ...

today announced that it has concluded dosing of Cohort A patients in the ACHIEVE Phase 2B UK clinical trial. The available data show a favorable safety and efficacy response in Cohort A patients ...

The initial Cohort B patient has completed the dosing regiment ... The Company is conducting two investigator-initiated clinical trials for its unmodified gamma-delta T cell product line ...

today announced the first Cohort B patient in the ACHIEVE Phase 2B UK clinical trial, evaluating TCB008 in Acute Myeloid Leukemia, has completed the full dosing regiment. The ACHIEVE trial is an ...